伊戈爾(002922.SZ):光伏發電併網設備智能製造數字化工廠主廠房目前正在產能爬坡
格隆匯5月11日丨有投資者在投資者互動平台向伊戈爾(002922.SZ)提問,“請問吉安新投產的工廠,什麼時候滿產?二季度能貢獻多少產能?”
伊戈爾回覆稱,公司2020年募投項目光伏發電併網設備智能製造數字化工廠主廠房已於2022年10月開始投產,目前正在產能爬坡,輔助廠房計劃於今年6月底前投入使用,目前產能爬坡進展順利!二季度的業績情況詳見公司後續披露的定期報吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.